Page last updated: 2024-09-03

6-heptyne-2,5-diamine and Cancer of Ovary

6-heptyne-2,5-diamine has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergamaschi, D; D'Incalci, M; De Feudis, P; Desiderio, MA; Erba, E; Mascellani, E	1

Other Studies

1 other study(ies) available for 6-heptyne-2,5-diamine and Cancer of Ovary

Article	Year
Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors. British journal of cancer, 1997, Volume: 75, Issue:7 Topics: Alkynes; Antineoplastic Agents, Alkylating; Cell Cycle; Cell Survival; Deoxyadenosines; Diamines; DNA, Neoplasm; Enzyme Inhibitors; Female; Humans; Ornithine Decarboxylase Inhibitors; Ovarian Neoplasms; Polyamines; Spermine; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1997

Article

Year

Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors.

British journal of cancer, 1997, Volume: 75, Issue:7

Topics: Alkynes; Antineoplastic Agents, Alkylating; Cell Cycle; Cell Survival; Deoxyadenosines; Diamines; DNA, Neoplasm; Enzyme Inhibitors; Female; Humans; Ornithine Decarboxylase Inhibitors; Ovarian Neoplasms; Polyamines; Spermine; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1997